# Himedi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/himedi

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.himedi.com
- Total disclosed funding: $6.7M
- Latest round: Series B (Apr 20, 2020)
- Investors on record: 4

## About

Based in South Korea, Himedi, Inc. specializes in providing premium medical tourism concierge services, focusing on facilitating medical checkups and health screenings for international clients.Himedi, Inc. was founded in 2011 in Seoul, South Korea, to assist individuals seeking medical services abroad. The company has successfully completed a total of 3 deals, with its most recent funding round occurring on December 22, 2021. During this round, Himedi raised KRW 3 billion from TBT Partners and White Star Capital. The CEO and co-founder, Donkyo Seo, has played a pivotal role in the company's development.Himedi provides a premium medical tourism concierge service in South Korea, primarily focusing on facilitating medical checkups and health screenings for international clients. The company's core offerings include comprehensive full-body checkups, specialized screenings such as Whole Body MRIs and fertility evaluations, and aesthetic procedures like body sculpting and skin analysis. These services cater to individuals seeking thorough health assessments and medical treatments in a streamlined, user-friendly manner, emphasizing accessibility for clients from North America, Europe, and Asia.Himedi generates revenue through direct transactions with clients booking medical services on its platform. The structure includes service fees for medical checkups and related procedures, with clients paying only for the treatments they select from Himedi's partnered medical facilities. For example, a typical comprehensive full-body checkup is priced at approximately USD 370, while a Whole Body MRI starts at USD 1,150. The company does not charge additional fees for concierge services, enhancing its appeal among customers looking for transparent and cost-effective healthcare solutions.Following its recent deal in December 2021, which raised KRW 3 billion, Himedi plans to utilize these funds to expand its global reach, targeting markets in Mongolia, Russia, Kazakhstan, and the Middle East Gulf Cooperation Council. The company is actively designing new products aimed at enhancing its service offerings, as it seeks to broaden its client base and improve accessibility to healthcare services.

## Funding rounds

- Series B, Apr 20, 2020, $4.9M — White Star Capital, Solidus Investment, Murex Partners, Lighthouse Combined Investment
- Series A, Oct 1, 2018, $1.8M — Murex Partners

## Investors

- Murex Partners (https://capitalatlas.ai/funds/murex-partners) — Series A, Series B
- White Star Capital (https://capitalatlas.ai/funds/white-star-capital) — Series B
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Series B
- Lighthouse Combined Investment (https://capitalatlas.ai/funds/lighthouse-combined-investment) — Series B